UPDATE: Bernstein Downgrades Regeneron Pharma (REGN) to Market Perform
Tweet Send to a Friend
(Updated - December 15, 2021 5:34 AM EST)
Bernstein analyst Aaron Gal downgraded Regeneron Pharma (NASDAQ: REGN) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Bernstein analyst Aaron Gal downgraded Regeneron Pharma (NASDAQ: REGN) from Outperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
